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Up to 15% of free-ranging mule deer in northeastern Colorado and southeastern Wyoming, USA,
are afflicted with a prion disease, or transmissible spongiform encephalopathy (TSE), known as
chronic wasting disease (CWD). CWD is similar to a subset of TSEs including scrapie and variant
Creutzfeldt–Jakob disease in which the abnormal prion protein isoform, PrPCWD, accumulates in
lymphoid tissue. Experimental scrapie studies have indicated that this early lymphoid phase is an
important constituent of prion replication interposed between mucosal entry and central nervous
system accumulation. To identify the lymphoid target cells associated with PrPCWD, we used triple-
label immunofluorescence and high-resolution confocal microscopy on tonsils from naturally
infected deer in advanced disease. We detected PrPCWD primarily extracellularly in association with
follicular dendritic and B cell membranes as determined by frequent co-localization with antibodies
against membrane bound immunoglobulin and CD21. There was minimal co-localization with
cytoplasmic labels for follicular dendritic cells (FDC). This finding could indicate FDC capture of
PrPCWD, potentially in association with immunoglobulin or complement, or PrPC conversion on FDC.
In addition, scattered tingible body macrophages in the germinal centre contained coarse
intracytoplasmic aggregates of PrPCWD, reflecting either phagocytosis of PrPCWD on FDC processes,
apoptotic FDC or B cells, or actual PrPCWD replication within tingible body macrophages. To
compare lymphoid cell targets in early and advanced disease, we also examined: (i) PrPCWD
distribution in lymphoid cells of fawns within 3 months of oral CWD exposure and (ii) tonsil biopsies
from preclinical deer with naturally acquired CWD. These studies revealed that the early lymphoid
cellular distribution of PrPCWD was similar to that in advanced disease, i.e. in a pattern suggesting
FDC association. We conclude that in deer, PrPCWD accumulates primarily extracellularly and
associated with FDCs and possibly B cells – a finding which raises questions as to the cells
responsible for pathological prion production.
Introduction
Chronic wasting disease (CWD) is the only prion disease,
or transmissible spongiform encephalopathy (TSE), known to
affect free-ranging wildlife (Spraker et al., 1997 ; Williams &
Young, 1992, 1993). In endemic areas of Colorado and
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Wyoming, USA, up to 15% of free-ranging mule deer are
infected (Miller et al., 2000) and the potential of CWD
transmission to livestock or humans is unknown. Even
transmission routes among deer remain obscure, although
epidemiological evidence suggests lateral transmission (Miller
et al., 2000). The pathogenesis of CWD is beginning to unfold.
Recent studies have revealed the abnormal isoform of the prion
protein (PrPres) in lymphoid tissue (Sigurdson et al., 1999) in a
pattern very similar to that described in natural scrapie of
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sheep (van Keulen et al., 1996) and variant Creutzfeldt–Jakob
disease (vCJD) of humans (Hill et al., 1999).
Lymphoid tropism differs among the TSEs – these differ-
ences possibly reflect variants of prion disease pathogenesis.
For example, in bovine spongiform encephalopathy (BSE)
no detectable PrPres or infectivity is detectable in spleen
(Somerville et al., 1997) or lymph nodes (Wells et al., 1998),
unlike CWD, sheep scrapie and vCJD (Hill et al., 1999 ; Spraker
et al., 2002 ; van Keulen et al., 1996). However, experimental
inoculation of BSE into sheep does result in detectable
lymphoid PrPres (Foster et al., 2001 ; Jeffrey et al., 2001).
Moreover, lymphotropism appears to be determined not only
by host species, but also by prion strain : for example, humans
with vCJD have lymphoid PrPres accumulation or infectivity
(Bruce et al., 2001 ; Hill et al., 1999 ; Hilton et al., 1998) whereas
humans with sporadic or iatrogenic CJD do not have lymphoid
PrPres accumulation (Hill et al., 1999).
Naturally infected deer with advanced CWD have CWD
PrPres (PrPCWD) disseminated throughout lymph nodes,
spleen, tonsils and Peyer’s patches. In tonsils, PrPCWD
accumulation is restricted primarily to germinal centres and is
present in " 50% of secondary follicles (Spraker et al., 2002). In
fawns orally inoculated with CWD brain homogenate, PrPCWD
was detected in alimentary-associated lymphoid tissues as
early as 6 weeks post-inoculation (p.i.). In these early stages of
infection, PrPCWD was limited to ! 30% of secondary follicles,
which were typically clustered, suggesting a common conduit
or seeding site into the draining lymph node (Sigurdson et al.,
1999).
The mechanisms of lymphoid tissue PrPCWD accumulation
remain uncertain, although studies in natural and experimental
scrapie (Andreoletti et al., 2000 ; Brown et al., 2000 ; Jeffrey et
al., 2000 ; Kitamoto et al., 1991 ; McBride et al., 1992 ; Montrasio
et al., 2000), CJD in mice (Manuelidis et al., 2000) and vCJD in
humans (Hill et al., 1999) provide evidence for PrPres
association with follicular dendritic cells (FDC) and}or tingible
body (TB) macrophages. With the abundant PrPCWD in
lymphoid tissues of deer, it seems possible that PrPCWD-
containing lymphoid cells could traffic into the blood. Several
studies have established that PrPres strongly correlates with
infectivity (Bolton et al., 1991 ; McKinley et al., 1983 ; Race et
al., 1998). Therefore, with the hope of gaining insight into
potential trafficking, conversion or capture sites of PrPCWD, we
studied the spatial relationship of the protease-resistant prion
protein to lymphoid cell phenotypes in the tonsils and lymph
nodes of mule deer naturally or experimentally infected with
CWD by triple-immunofluorescent labelling and laser scanning
confocal microscopy. We found PrPCWD almost exclusively in
association with cell membrane surfaces. In addition, smaller
deposits of PrPCWD were detected intracytoplasmically in
CD68+ macrophages or dendritic cells within germinal centres
and much less commonly within the paracortical zone of lymph
nodes. These results are reminiscent of those of Jeffrey et al.
(2000) regarding PrPSc and suggest to us that either : (a)
PrPCWD conversion occurs at the surface rather than within
FDCs or (b) PrPCWD formation occurs at distant sites and is
concentrated at FDC surfaces.
Methods
+ CWD-infected deer and tissue collection. Tonsils or retro-
pharyngeal lymph nodes from CWD-positive deer were acquired from
three groups of captive mule deer (Odocoileus hemionus) in various stages
of infection : (1) tonsils from six deer with naturally occurring, clinical
CWD, (2) retropharyngeal lymph nodes from two fawns orally inoculated
with a CWD brain homogenate and euthanized at 42 and 78 days p.i., and
(3) tonsil biopsies from three naturally infected, asymptomatic deer from
a captive herd with endemic CWD. The asymptomatic deer eventually
developed clinical signs of CWD and were euthanized (CWD confirmed
with brain immunohistochemical staining (IHC) for PrPCWD). Tonsils
were fixed in 10% neutral buffered formalin for 1–3 days then immersed
in 88% formic acid for 1 h and embedded in paraffin.
The clinically affected CWD-positive deer were diagnosed by : (1)
histological lesions of CWD in the medulla oblongata including
perikaryonic neuronal vacuoles, spongiform degeneration of the neuropil
and astrocytosis, and (2) abundant PrPCWD staining in the medulla
oblongata by IHC (methods described in Sigurdson et al., 2001). Deer
were confirmed as CWD-negative by the absence of histological brain
lesions and negative staining for PrPCWD in brain and tonsil.
+ Negative control deer and tissues. Tonsils from CWD-negative
mule deer were acquired from two sources : (1) adult deer from the CWD
non-endemic area (non-endemic area established by methods in Miller et
al., 2000) and (2) two mule deer fawns inoculated with CWD-negative
brain homogenate from a previous study (Sigurdson et al., 1999). Tissues
were similarly fixed and processed.
+ Phenotype antibodies. Several antibodies which recognize
lymphoid epitopes on deer lymphoid cells were used. These included
antibodies which recognize : (1) lambda light chain (DAKO), present in
antigen–antibody complexes on FDC membrane surfaces and on B cells,
(2) cc21 (CD21 or complement receptor type 2) (antibody generously
donated by Dr Chris Howard), a receptor that traps immune complexes
on FDC surfaces also expressed by B cells (Zabel & Weis, 2001), (3) CD68
(Serotec), an intracytoplasmic, lysosome-associated epitope within
macrophages and human DC (Betjes et al., 1991), (4) ferritin (DAKO), a
large protein surrounding a core of ferric oxide which functions to store
and detoxify iron (Morikawa et al., 1995) in macrophages (Kindblom et al.,
1982), (5) heat shock protein 70 (HSP70) (DAKO) in macrophages
(Bachelet et al., 1998), (6) vimentin (DAKO), an intermediate filament in
TB macrophages (Giorno, 1985) and FDC (Tsunoda et al., 1990), (7) anti-
FDC (DAKO), which targets a 120 kDa epitope in FDC of humans
(Raymond et al., 1997) and has been shown to cross-react with sheep FDC
(Lezmi et al., 2001), (8) S100 (DAKO), a calcium-binding protein present
in FDC and}or TB macrophages, depending on the species (Carbone et
al., 1988), and (9) CD3 (DAKO), an intracytoplasmic domain of the CD3
epsilon chain of T cells.
+ Immunofluorescent staining. Tissue sections (6 lm) were
mounted onto positively charged glass slides, deparaffinized, hydrated,
autoclaved in a buffer solution (DAKO Target Antigen Retrieval) for
12 min at 121 °C, and cooled for 5 min. Sections were rinsed in PBS and




for 15 min to quench endogenous peroxidase.
Sections were then briefly rinsed in PBS and incubated in TNB blocking
solution (NEN Sciences) for 30 min followed by exposure to 1–2
lymphoid phenotype antibodies and anti-PrP antibody 6H4 (monoclonal,
IgG, 1 :200 dilution) or R522 (polyclonal, 1 :1500 dilution) for 30 min at
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room temperature. mAb 6H4 recognizes a conserved sequence of the
prion protein, corresponding to the human amino acid sequence 144–152
(Korth et al., 1997). R522 recognizes ovine PrP 94–105 (Garssen et al.,
2000 ; van Keulen et al., 1995). Antibodies were diluted in a protein block
containing goat serum (Biogenex).
Since HSP epitopes appear to be destroyed by autoclaving, slides
stained for HSP and PrP were initially labelled for HSP, followed by
autoclaving and labelling for PrPCWD. In general, phenotype antibodies
were labelled with FITC or Alexa 488 (Molecular Probes) and PrP
labelled with CY3. In sections labelled for HSP or CD68, PrPCWD was
labelled with FITC. Tyramide amplification (NEN Sciences) was used to
enhance stain signal on R522, ferritin and HSP labels. Slides were
coverslipped using anti-fade mounting media (Molecular Probes). CWD-
negative deer tissues were incubated with an anti-PrP antibody and an
isotype- and concentration-matched rabbit or mouse antibody to control
for the phenotype antibody.
+ Confocal microscopy. To co-localize the cell phenotype marker
and PrPCWD, triple immunofluorescently labelled sections were examined
using an Olympus FLUOVIEW laser scanning confocal microscope
equipped with 12-bit resolution which allows for data acquisition from
three fluorescent channels using three lasers, Argon 488 nm, HeNe
543 nm and HeNe 622 nm; these emit in the green, red and far-red
spectra, respectively. Secondary follicles were selected from each tonsil
section and sequentially scanned using the three lasers.
+ Quantification of co-localization of PrPCWD and phenotype
marker. Images from each deer were analysed using Metamorph
software (Universal Imaging Corp., West Chester, PA) applying the
colour thresholding tool to differentiate the positively stained cells from
the unstained cells. Percent co-localization of PrPCWD with the phenotype
marker stain was measured using the co-localization tool and recorded on
a Microsoft Excel spreadsheet. For each tissue section, two follicles
(900‹ magnification) were analysed for PrPCWD and phenotype marker
co-labelling, and the results were averaged. Data were analysed using
Student’s t-test. Significance was defined at P! 0–05.
+ Dual immunocytochemical (ICC) staining. To determine
whether PrPCWD could be associated with individual cells from a CWD-
infected lymph node, we collected the retropharyngeal lymph node
into cold cell culture medium immediately after euthanasia. Single cell
suspensions were prepared by mincing and incubating 2 mm$ sections in
serum-enriched medium containing collagenase, dispase and DNase at
37 °C with agitation to digest the stroma and release the cells. The cells
were pelleted by centrifugation, washed in PBS, and then cytocentrifuged
onto positively charged glass slides. Cells were fixed in 10% buffered
formalin for 15 min and pretreated by hydrated autoclaving if necessary
immediately prior to immunostaining.
The ICC protocol employed an automated immunostainer (Ventana
Medical Systems) and was separated into two stages. First, the cells were
labelled with a phenotype marker using the appropriate phenotype
antibody, a biotinylated secondary antibody, a horseradish peroxidase–
streptavidin conjugate and a diaminobenzadine chromagen. Second,
hydrated autoclaving was performed on cell preparations not previously
autoclaved and the cells were labelled for PrPCWD using PrP mAb
F99}97.6.1 (generously provided by Dr Katherine O’Rourke) (Spraker et
al., 2002), a biotinylated secondary antibody, an alkaline phospha-
tase–streptavidin conjugate, a substrate chromagen (fast red A), and a
haematoxylin and bluing counterstain (Ventana Medical Systems). mAb
F99}97.6.1 reacts with a conserved epitope (residues QYQRES) on the
prion protein of mule deer, Rocky Mountain elk, domestic sheep and
cattle (Spraker et al., 2002). An isotype-matched, irrelevant antibody was
substituted in the ICC protocol as a negative control for the phenotype
marker. The anti-PrP antibody was applied to both CWD-negative and
-positive deer cell preparations.
IHC was performed on lymphoid tissue as described for the ICC
utilizing anti-PrP mAbs F89}160.1.5 and F99}97.6.1. mAb F89}160.1.5
recognizes a conserved epitope of the prion protein of mule deer, elk,
sheep and cattle (residues IHFG) (O’Rourke et al., 1998).
Results
Lymphoid cells in the germinal centres include FDC, TB
macrophages, T and B lymphocytes, and germinal centre
dendritic cells. Germinal centre dendritic cells, a dendritic cell
subset in the tonsil that presents antigen to germinal centre B
cells, have been described in humans (Grouard et al., 1996 ;
Summers et al., 2001) but not in ruminants.
Because PrPCWD deposits accumulate within germinal
centres of primary and secondary lymphoid follicles, we
focused on phenotype marker antibodies which would target
FDC, B and T lymphocytes, and TB macrophages. To ensure
that the human antigen-derived phenotype antibodies recog-
nized the appropriate target epitope, we compared the cell
staining patterns of our phenotype antibodies in human and
deer tonsil sections and determined that the antibodies
identified lymphoid cells with similar morphology and ana-
tomical distribution.
PrPCWD in lymphoid germinal centres
In tonsils of all CWD-infected deer examined by IHC,
PrPCWD was concentrated primarily in lymphoid follicle
germinal centres (Fig. 1). Tonsils from deer with clinical CWD
or tonsil biopsies from preclinical, CWD-infected deer had a
Fig. 1. Typical abundant follicular PrPCWD deposition in a lymph node
follicle from a deer with advanced CWD. Note the network-like lattice of
PrPCWD deposition defining the central zone of the follicle (bracket) and
isolated PrPCWD-positive cells at the periphery of the follicle (arrows).
Anti-PrP antibody used: F99/97.6.1. Bar, 10 lm.
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Fig. 2. PrPCWD is on the cell surface of FDC. Lymphoid follicle within a CWD-positive deer tonsil stained using two triple-
labelling protocols. PrPCWD(panels a, e, red, antibody 6H4) co-localizes with cell membrane markers for cc21 and
immunoglobulin (Ig) (panels c, g, blue) visible as pink in the merged image (panels d, h). PrPCWD (red) does not co-localize
with intracellular FDC labels, S100 and FDC (green), as apparent by the lack of yellow in merged images (panels d, h).
Bar, 50 lm.
Fig. 3. Lymphoid follicle, CWD-positive deer tonsil. PrPCWD (panel b, red, antibody 6H4) co-localizes strongly with membrane-
bound lambda light chain of immunoglobulin (Ig, blue) and poorly with the intracellular marker vimentin (panels a, c). Lower
magnification, serial sections from the same field show different planes C1 lm apart from top to bottom and demonstrate the
strong co-localization of PrPCWD and Ig and the poor co-localization of PrPCWD and vimentin through the specimen. Bars, 10 lm
(a), 20 lm (b).
high frequency (C 80–100%) of PrPCWD-positive follicles. By
contrast, in fawns examined 7 to 11 weeks after oral CWD
exposure, ! 30% of retropharyngeal lymph node follicles
contained detectable PrPCWD. Although PrPCWD was found
primarily within the germinal centres, it was also detected
occasionally in cells within perifollicular areas (Fig. 1).
PrPCWD accumulates on FDC membranes
To study the association of PrPCWD with germinal centre
cells, we co-labelled tonsil sections for PrPCWD, FDC and other
lymphoid cell phenotypes. Three cytoplasmic phenotype
markers were used to identify FDC: S100, vimentin and anti-
CGCA
PrPCWD lymphoid cell targets
Fig. 4. PrPCWD associates with cell
membranes on follicular dendritic and B
cells. Tonsillar germinal centre, high
magnification. (a) PrPCWD is on membrane
surfaces and dendritic processes of FDCs
(arrows). (b) PrPCWD co-localizes with
cc21 (CD21) on membrane surfaces
(arrowheads, pink) and poorly with
intracellular S100 (note no yellow)
indicating that PrPCWD accumulates on cell
surfaces. Nucleus is likely the central
round black structure (arrow). FDC cell
membrane is designated by the white
dotted line. Side panel to the right of
main panel is the same cell viewed on a
perpendicular plane across the pink line
and the lower panel shows a section
perpendicular to the yellow line in the
main panel (Tfl top, B flbottom). These
views demonstrate that there is no
discernible PrPCWD within the cytoplasm
of the FDC; PrPCWD is between the cells.
Anti-PrP antibody used: 6H4. Bar, 10 lm.
FDC (see Methods for details on antibodies). To investigate
whether PrPCWD accumulated on the cell membrane or
cytoplasmically with respect to FDC, we also triple-labelled
tonsil sections with antibodies targeting two membrane-bound
epitopes associated with FDC and B cell membranes : lambda
light chain and cc21 (CD21 or complement receptor type 2).
Using confocal microscopy, we found that co-localization of
PrPCWD with the FDC intracellular phenotype markers was
rare, though PrPCWD appeared in close association with FDC
(Fig. 2).
Although the lack of co-localization of PrPCWD with the
FDC cytoplasmic markers (S100 and anti-FDC) was visually
apparent as assessed by the lack of yellow stain, we quantified
and compared the co-localization of PrPCWD with intracyto-
plasmic and membrane markers using Metamorph software.
PrPCWD co-localization with the extracellular markers was
approximately four times higher than with intracellular FDC
markers (P! 0–05 by Student’s t-test ; Fig. 5). We concluded
that PrPCWD accumulated primarily on membranes associated
with FDC and B lymphocytes.
To verify our results, we analysed tonsil sections labelled
with the intracytoplasmic marker vimentin at a higher
CGCB



















Fig. 5. Percentage PrPCWD co-localization with intracellular markers for FDC
(S100, FDC) or cell membrane markers (immunoglobulin, cc21). nfl12.
magnification (900‹ with zoom) and created a stack of
individual optical sections C 0–3 microns apart through the
tissue. At high magnification, PrPCWD co-localized strongly
with lambda light chain and poorly with vimentin (Fig. 3a–c) ;
Fig. 6. PrPCWD-containing cells (arrows) are peripheral to the lymph node follicle. Cells are labelled by immunohistochemistry
(a, b) or by triple-immunofluorescence (c, d). Panels (c) and (d) demonstrate PrPCWD labelling (red, antibody R522) in CD68+
cells (green, macrophages or dendritic cells) using confocal microscopy. Nuclei are labelled blue. Bars, 1 mm (a) or 10 lm (b).
this labelling pattern was consistent throughout the thickness
of the tissue section (Fig. 3d–h).
We then characterized PrPCWD in relation to individual
cells at high magnification. Using the FDC intracytoplasmic
label (S100) and a nuclear stain, we found that PrPCWD was
present on the plasma membrane surface and on the fine
processes of the FDC (Fig. 4a). Perpendicular sections through
a cell labelled with S100 and cc21 antibodies indicated that
even in three-dimensional views PrPCWD co-localized only
with the plasma membrane marker and did not appear to be
intracytoplasmic (Fig. 4b).
To determine whether T cells may harbour PrPCWD, we co-
labelled tonsil sections for PrPCWD and T cell receptor CD3.
We found that relatively low numbers of T cells were present
and no consistent intimate association was evident between
these CD3+ cells and PrPCWD (data not shown).
PrPCWD in the cytoplasm of TB macrophages
Perifollicular cells containing PrPCWD were seen in
chromagen-based IHC staining of lymph nodes (Fig. 6a, b). To
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Fig. 7. Tonsillar follicle from a CWD-positive deer. PrPCWD (red, antibody 6H4) is detected within cells positive for HSP (green),
presumably macrophages (a, b). (b) Higher magnification of cell from panel (a) (white box) shows close approximation of
PrPCWD and HSP likely within a single cell. Serial sections of a single cell (yellow box, panel 1) from top to bottom were
obtained C1 lm apart and demonstrate the presence of PrPCWD and HSP70 within the cytoplasm (c–f). Nuclei are labelled
blue. Bars, 15 lm (a), 2–5 lm (b), 5 lm (c–f).
phenotype these cells, we triple-labelled a tonsil section using
antibodies against PrPCWD, nuclei and CD68, which labels a
lysosomal epitope of macrophages and human dendritic cells,
and found that PrPCWD was associated with CD68+ macro-
phages or dendritic cells (Fig. 6c, d).
We investigated whether TB macrophages were involved
in PrPCWD accumulation based on earlier experiments in which
PrPCWD staining was visualized in cells morphologically
characteristic of TB macrophages (see Fig. 9). To determine
whether TB macrophages in germinal centres accumulated
PrPCWD, we used three intracellular antibody markers for TB
macrophages : CD68, HSP70 and ferritin.
In HSP70-labelled sections examined at high magnification,
we found that PrPCWD was closely associated with HSP70 (Fig.
7a, b). Serial optical sections through a single cell consistently
demonstrated PrPCWD adjacent to the intracellular TB macro-
phage marker (HSP70), indicating that PrPCWD was intra-
cellular (Fig. 7c–f). Similar results were seen with the ferritin
label (data not shown). At high magnification, PrPCWD
occasionally co-localized with the macrophage phenotype
marker CD68 (Fig. 8). To conclude, two populations of
macrophages contained PrPCWD : (1) TB macrophages within
germinal centres and (2) isolated macrophages or possibly
dendritic cells in the perifollicular area.
PrPCWD in separated lymphoid cells
In a further attempt to determine whether PrPCWD was
membrane associated and affiliated with FDC, we examined
lymphoid cells enzymatically digested from a CWD-infected
retropharyngeal lymph node. Using cytospin preparations of
lymphoid cells stained for S100 and PrPCWD, we found that
many PrPCWD-bearing cells labelled for S100, identifying them
as FDC (Fig. 9). In addition, however, some PrPCWD-containing
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Fig. 8. CD68+ cell (green) within the germinal centre contains PrPCWD (red, arrow, antibody R522). Nuclei are labelled blue.
Bar, 5 lm.
Fig. 9. TB macrophages contain PrPCWD. (a) Tonsil biopsy from a deer with pre-clinical CWD demonstrating PrPCWD in cells
morphologically consistent with TB macrophages. Note condensed fragmenting nuclei within the cytoplasm (arrows). (b) S100-
positive cell (brown) dually labelled for PrPCWD (red) from a cytospin preparation of an enzymatically dissociated CWD-positive
deer lymph node. Anti-PrP antibodies used: F89/160.1.5 (a) ; F99/97.6.1 (b). Bar, 10 lm.
cells also stained positively for ferritin, a trait most compatible
with macrophages. Occasionally PrPCWD-positive cells also
co-labelled for lambda light chain or vimentin, traits compatible
with FDC, TB macrophages or B cells. These experiments
demonstrated that : (1) PrPCWD was cell associated, and (2)
PrPCWD-harbouring cells were positive for either S100, ferritin,
vimentin or lambda light chain, confirming that at least FDC
and macrophages were accumulating PrPCWD.
PrPCWD lymphoid cell association in preclinical
CWD-infected deer
To determine whether the lymphoid cell association of
PrPCWD changed through the course of infection, we compared
PrPCWD lymphoid target cells from deer in early, asymptomatic
stages of infection to deer with clinical signs of advanced
CWD. The PrPCWD distribution in tonsil biopsies from
asymptomatic, naturally exposed deer was similar to that in the
tonsils from clinically affected deer. In contrast, in fawns
sacrificed 6–11 weeks post-oral inoculation, PrPCWD was
distributed primarily on FDC and B cell membrane surfaces
with less involvement of TB macrophages. One fawn (6 weeks
p.i.) had no apparent PrPCWD in TB macrophages ; PrPCWD was
primarily associated with cell membranes. In a second fawn (11
weeks p.i.) PrPCWD was detected in both the cell membrane
(FDC}B cells) and intracellular (TB macrophages) patterns.
These studies suggested that PrPCWD accumulated first in
association with FDC vs macrophages and that no additional
cell associations were apparent in early pre-clinical stages of
infection.
Discussion
A prominent feature of CWD in mule deer is the abundant
PrPCWD accumulation in lymphoid germinal centres, similar to
that in variant CJD in humans (Hill et al., 1999 ; Hilton et al.,
1998) and scrapie in sheep (Andreoletti et al., 2000 ; Heggebø
et al., 2000 ; van Keulen et al., 1996). PrPSc}PrPCWD or
infectivity is initially detectable in alimentary-associated
lymphoid tissue within weeks following oral exposure and
months before detection in the brain (Andreoletti et al.,
2000 ; Hadlow et al., 1982 ; Kimberlin & Walker, 1989 ;
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Fig. 10. Working model for lymphoid cells associated with PrPCWD. PrPCWD (red) accumulates on the cell membrane or
extracellularly in association with the FDC and/or B cells and accumulates within the cytoplasm of TB macrophages.
Sigurdson et al., 1999 ; van Keulen et al., 2000 ; Williams &
Miller, 2000). While PrPCWD accumulates in lymph nodes in
these early stages of infection, the role of specific immune
system cells in prion replication and trafficking to the central
nervous system (CNS) remains unclear.
Our observations indicate that PrPCWD accumulates in
close association with FDC (Fig. 10). Due to the close contact
of FDC processes with numerous B cells (emperiopolesis), it is
possible that PrPCWD is also on B cell membranes, or is in the
extracellular space between FDC and B cells. This finding is
consistent with two recent studies in the mouse TSE models
demonstrating FDC membrane-associated PrPSc : Jeffrey et al.
(2000) used immunogold labelling to elegantly demonstrate
ME7 PrPSc on the plasmalemma of splenic FDC. Secondly,
Manuelidis et al. (2000) used confocal microscopy to localize
strain FU CJD PrPres on FDC membranes. Interestingly, the
localization of infectious agent to FDC is not unique to TSEs.
Other infectious agents, especially viruses, have been described
on FDC surfaces, including bovine viral diarrhoea (Fray et al.,
2000) and human immunodeficiency viruses (Fujiwara et al.,
1999 ; Joling et al., 1993 ; Schmitz et al., 1994).
Although FDC have been associated with PrPSc (Brown et
al., 1999 ; Hill et al., 1999 ; Kitamoto et al., 1991 ; McBride et al.,
1992 ; Ritchie et al., 1999), whether FDC replicate or merely
harbour prions remains controversial. For example, Montrasio
et al. (2000) demonstrated that inhibition of FDC development
virtually eliminated splenic PrPSc. Mabbott et al. (2000) found
similar results if mice had FDC deleted prior to scrapie
challenge ; however, when FDC were deleted after challenge,
mice developed high levels of splenic infectivity. Moreover, in
experiments using chimeric mice in which PrPC expression
between FDC and other lymphoid cells was mismatched,
Brown et al. (1999) found that only those mice expressing PrPC
in FDC were susceptible to scrapie, strongly suggesting prion
propagation by FDC. In contrast, Manuelidis et al. (2000)
concluded that limiting intraperitoneal doses of CJD into FDC-
deficient mice resulted in only a slightly prolonged incubation
period over wild-type controls, suggesting FDC do not play a
key role in this model. In our confocal microscopy study of
PrPCWD in deer tonsils, serial images through FDC failed to
reveal intracytoplasmic PrPCWD, which might indicate that
FDC do not uptake or convert appreciable PrPCWD in the
cytoplasmic compartment. This finding suggests that FDC
may convert PrPC at the cell membrane or that intracellular
conversion may be followed by rapid PrPCWD exocytosis.
Another possibility would be that the FDC could act as
scaffold for passive capture of PrPCWD on the cell membrane,
potentially in association with complement or Fc- c receptors.
The association of PrPCWD on cell membranes is consistent
with recent evidence for complement involvement in prion
pathogenesis, shown by Klein et al. (2001) and Mabbott et al.
(2001).
Unlike the membrane-associated PrPCWD of FDC, intra-
cytoplasmic large, dense aggregates of PrPCWD were detected
in TB macrophages. This finding is reminiscent of studies
showing PrPSc deposits associated with CD68+ cells
(Andreoletti et al., 2000) or cells morphologically consistent
with TB macrophages in naturally infected scrapie sheep (van
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Keulen et al., 1996). Moreover, Jeffrey et al. (2000) described
PrPSc in lysosomes of TB macrophages, consistent with
immunogold electron microscopy studies localizing PrPSc in
lysosomes of neurons (Laszlo et al., 1992).
There are several potential roles for the TB macrophages in
prion pathogenesis. It is possible that CD68+ dendritic cells or
macrophages transport PrPCWD into the germinal centre and
expose the FDC, T and B cells to PrPCWD. CD68+ cells
harbouring PrPCWD or PrPSc (Andreoletti et al., 2000) have
been localized adjacent to germinal centres. However, TB
macrophages are in close contact with FDC and are known to
phagocytose immune complex-coated bodies (iccosomes) on
FDC membranes (Szakal et al., 1988). TB macrophages may
phagocytose PrPCWD-retaining FDC cell fragments (Heinen et
al., 1993) and extracellular PrPCWD amyloid, and may or may
not replicate PrPCWD, as suggested by Jeffrey et al. (2000). In
addition, TB macrophages phagocytose apoptotic B cells,
which also could serve as a potential source of PrPCWD
exposure. Therefore, PrPCWD accumulation in TB macrophages
may be a secondary event which follows FDC PrPCWD
accumulation.
While CD3+ T cells were present in germinal centres, a
consistent association between these cells and PrPCWD depo-
sits was not detected, although this association was difficult to
assess due to the low number of T cells. Studies with scrapie in
transgenic and immunodeficient mice suggest that T cells do
not affect disease susceptibility or splenic infectivity (Klein et
al., 1997, 1998). Nevertheless, the involvement of T cells in
CWD pathogenesis remains an open question.
Although PrPCWD was primarily localized to germinal
centres, PrPCWD was not restricted to follicles in all lymphoid
tissue studied. Scattered cells in the paracortical zone and
medullary cords of lymph nodes occasionally contained
PrPCWD. These cells invariably labelled for CD68, indicating
that they were either macrophages or dendritic cells.
Surprisingly few differences in the lymphoid cells associated
with PrPCWD were seen in fawns weeks after oral exposure to
CWD when compared to naturally infected deer with advanced
CWD. One fawn at 6 weeks p.i. had PrPCWD extracellularly
with no detectable involvement of TB macrophages. We
speculate that the TB macrophages may be phagocytosing
extracellular PrPCWD iccosomes and that there is a short lag
before TB macrophages contain PrPCWD. This scenario could
explain why 1 fawn (6 weeks p.i.) had no apparent PrPCWD in
TB macrophages versus a second fawn (11 weeks p.i.). In
scrapie-inoculated mice at 70 and 170 days p.i., the cell
labelling of PrPSc was similar at both time-points (Jeffrey et al.,
2000). In contrast, in sheep naturally infected with scrapie,
PrPSc was apparent in CD68+ cells prior to detection in FDC
(Andreoletti et al., 2000).
The close association of PrPCWD with the membrane
surfaces of FDC and B cells and the presence of intracyto-
plasmic PrPCWD in TB macrophages raises questions as to the
contribution of each of these cell types to PrPCWD replication
and trafficking. Our findings in naturally infected deer add to
those in CJD- and scrapie-infected mice, and may lend insight
into the lymphoid cell targets in vCJD. Understanding
peripheral lymphoid reservoirs may be central to deciphering
prion trafficking routes from mucosal surfaces and could be
critical to diagnostic and intervention measures during the
preclinical stages of prion infections.
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